Cancer Immunotherapy
  • Featured content
    In this expert analysis, John M. Burke, MD, and Jeff P. Sharman, MD, review key data from the most clinically relevant studies on the management of lymphomas and CLL presented at the Hematology 2016 annual meeting.
  • Featured content
    Download this checklist resource as a guide for important discussion points to have during your consultations with patients with advanced NSCLC and their caregivers.
    Date Posted: 1/25/2017
  • Featured content
    In this downloadable slideset, Margaret Callahan, MD, PhD; Shirish Gadgeel, MD; Ryan T. Merrell, MD; Bradley J. Monk, MD, FACS, FACOG; and Joyce O’Shaughnessy, MD, review important clinical presentations across multiple cancers from the 2016 oncology meeting in Copenhagen.
    Date Posted: 12/12/2016
  • Featured content
    In this CME-certified module, Geoffrey T. Gibney, MD, discusses promising research showing benefit to IDO inhibition approaches in early-phase studies in melanoma, lung cancer, and other cancers.
  • Featured content
    In this downloadable slideset, Osama E. Rahma, MD, provides an overview of immunotherapy in cancer, including tumor immunology and evolution of immune checkpoint inhibitors in solid tumors, from a satellite symposium at the 2016 American Association for the Study of Liver Diseases Annual Meeting.
    Date Posted: 11/11/2016
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 291 Shown
10 of 291 Shown
Show 10 More